This two-volume reference book will present imaging technology currently used in clinics or at experimental stages for diagnosis and/or early detection of various cancers, including anticancer vaccines, surgical techniques, chemotherapy, radiation, and gene therapies. Cancers discussed will include
Breast Cancer Imaging and Therapy
β Scribed by Jean Seely (editor)
- Publisher
- Mdpi AG
- Year
- 2023
- Tongue
- English
- Leaves
- 230
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
In Canada, survival from breast cancer has steadily increased since 1989, and breast cancer mortality has decreased by 48%. While 82% of women with breast cancer are diagnosed at stage 1 or 2, there are still 18% who present at a late stage and 25% who develop metastatic disease. Improved survival has been achieved through early diagnosis of breast cancer with screening, allowing for more effective and targeted treatments. This reprint summarizes the latest evidence on the early detection of breast cancer and highlights areas where this may be improved.
β¦ Table of Contents
A9R1r9wrvf_kyqst_ga0.pdf
Breast Cancer Imaging and Therapy-1.pdf
A9R1r9wrvf_kyqst_ga0
π SIMILAR VOLUMES
This second of two volumes on Cancer Imaging covers the three major topics of imaging instrumentation, general imaging applications, and imaging of a number of human cancer types. Where the first volume emphasized lung and breast carcinomas, Volume 2 focuses on prostate, colorectal, ovarian, gastroi
This two-volume reference book will present imaging technology currently used in clinics or at experimental stages for diagnosis and/or early detection of various cancers, including anticancer vaccines, surgical techniques, chemotherapy, radiation, and gene therapies. Cancers discussed will include
<p>Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions
<p>It has been recognized for many years that cancers originating in the breast and prostate gland are frequently 'endocrine-dependent. ' Traditional theraΒ pies included surgical endocrine ablative procedures or pharmacologic horΒ mone administration, both designed to antagonize the stimulatory eff
<p>Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions